GE Healthcare optimistic on China

 24-Jan-17, Med Device Online 

GE Healthcare had a strong 2016 fourth quarter performance led by over 19 percent growth in China. For 2017, the company expects momentum to carry over for markets in China, Africa, and the Asia Pacific, while Europe will be stable. The United States market, however, is expected to slow down due to uncertainty over a looming repeal of the Affordable Care Act.

Image; GE Healthcare

Orders in the fourth quarter grew 3 percent to USD5.4 bn, steered by emerging markets, which grew 10 percent. China led all markets, followed by Latin America. Europe posted a modest 6 percent growth, but the US market contracted by 1 percent.

"We will launch 25 new products and are targeting a point of share in 2017. We expect China, Africa and Asia Pacific to continue their strong growth. Europe is expected to be roughly stable, while the US maybe a bit slower due to the uncertainty around the repeal or replace of the Affordable Care Act," reported Jeff Bornstein, GE SVP and CFO.

 Read the full article  

 Insights